IBDEI0LA ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1510,0)
 ;;="C" DIAGNOSIS^5^170
 ;;^UTILITY(U,$J,358.4,1511,0)
 ;;="B" DIAGNOSIS^4^170
 ;;^UTILITY(U,$J,358.4,1512,0)
 ;;="A" DIAGNOSIS^3^170
 ;;^UTILITY(U,$J,358.4,1513,0)
 ;;=PARAPLEGIA^1^170
 ;;^UTILITY(U,$J,358.4,1514,0)
 ;;=QUADRAPLEGIA^2^170
 ;;^UTILITY(U,$J,358.4,1515,0)
 ;;=NEW PT-OFFICE^3^171
 ;;^UTILITY(U,$J,358.4,1516,0)
 ;;=ESTABLISHED PT-OFFICE^1^171
 ;;^UTILITY(U,$J,358.4,1517,0)
 ;;=CONSULTATIONS^5^171
 ;;^UTILITY(U,$J,358.4,1518,0)
 ;;=COGNITIVE DISORDERS^1^172
 ;;^UTILITY(U,$J,358.4,1519,0)
 ;;=DEVELOPMENTAL DISORDERS^2^172
 ;;^UTILITY(U,$J,358.4,1520,0)
 ;;=LATE EFFECTS OF CEREBROVASCULAR DIS^5^172
 ;;^UTILITY(U,$J,358.4,1521,0)
 ;;=VOCAL FOLD DISORDER^10^172
 ;;^UTILITY(U,$J,358.4,1522,0)
 ;;=OTHER SPEECH DISORDERS^7^172
 ;;^UTILITY(U,$J,358.4,1523,0)
 ;;=HISTORY OF MALIGNANCY^3^172
 ;;^UTILITY(U,$J,358.4,1524,0)
 ;;=PSYCHOGENIC^8^172
 ;;^UTILITY(U,$J,358.4,1525,0)
 ;;=SWALLOWING DISORDER^9^172
 ;;^UTILITY(U,$J,358.4,1526,0)
 ;;=HISTORY/STATUS CODES^4^172
 ;;^UTILITY(U,$J,358.4,1527,0)
 ;;=NON-PSYCHOTIC MENTAL DISORDER^6^172
 ;;^UTILITY(U,$J,358.4,1528,0)
 ;;=ESTABLISHED PATIENT^2^173
 ;;^UTILITY(U,$J,358.4,1529,0)
 ;;=GROUP TREATMENT^3^174
 ;;^UTILITY(U,$J,358.4,1530,0)
 ;;=VOICE PROSTHESES^9^174
 ;;^UTILITY(U,$J,358.4,1531,0)
 ;;=AAC DEVICES^1^174
 ;;^UTILITY(U,$J,358.4,1532,0)
 ;;=OTHER PROCEDURES^6^174
 ;;^UTILITY(U,$J,358.4,1533,0)
 ;;=LARYNGOSCOPY PROCEDURES^4^174
 ;;^UTILITY(U,$J,358.4,1534,0)
 ;;=NASOPHARYNGOSCOPY^5^174
 ;;^UTILITY(U,$J,358.4,1535,0)
 ;;=DYSPHAGIA EVALUATION^2^174
 ;;^UTILITY(U,$J,358.4,1536,0)
 ;;=SPECIAL OTORHINOLARYNGOLOGIC SERVICES^8^174
 ;;^UTILITY(U,$J,358.4,1537,0)
 ;;=SCREENING^7^174
 ;;^UTILITY(U,$J,358.4,1538,0)
 ;;=SCREENING FOR MENTAL/DEVELOPMENT^24^175
 ;;^UTILITY(U,$J,358.4,1539,0)
 ;;=PERSONS SEEKING CONSULT^19^175
 ;;^UTILITY(U,$J,358.4,1540,0)
 ;;=MENTAL AND BEHAVIORAL PROBLEMS^13^175
 ;;^UTILITY(U,$J,358.4,1541,0)
 ;;=PROBLEMS RELATED TO LIFESTYLE^21^175
 ;;^UTILITY(U,$J,358.4,1542,0)
 ;;=ADMINISTRATIVE PURPOSES^3^175
 ;;^UTILITY(U,$J,358.4,1543,0)
 ;;=HOUSING & ECONOMIC CIRCUMSTANCES^12^175
 ;;^UTILITY(U,$J,358.4,1544,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^175
 ;;^UTILITY(U,$J,358.4,1545,0)
 ;;=ADJUSTMENT DISORDERS^2^175
 ;;^UTILITY(U,$J,358.4,1546,0)
 ;;=AMNESTICS^4^175
 ;;^UTILITY(U,$J,358.4,1547,0)
 ;;=ANXIETY DISORDERS^5^175
 ;;^UTILITY(U,$J,358.4,1548,0)
 ;;=BIPOLAR DISORDERS^6^175
 ;;^UTILITY(U,$J,358.4,1549,0)
 ;;=BRAIN DISORDERS^7^175
 ;;^UTILITY(U,$J,358.4,1550,0)
 ;;=DELIRIUM^8^175
 ;;^UTILITY(U,$J,358.4,1551,0)
 ;;=DEMENTIA^9^175
 ;;^UTILITY(U,$J,358.4,1552,0)
 ;;=DEPRESSION^10^175
 ;;^UTILITY(U,$J,358.4,1553,0)
 ;;=EATING DISORDERS^11^175
 ;;^UTILITY(U,$J,358.4,1554,0)
 ;;=MOOD DISORDERS (OTHER)^14^175
 ;;^UTILITY(U,$J,358.4,1555,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^15^175
 ;;^UTILITY(U,$J,358.4,1556,0)
 ;;=ORGANIC DISORDERS^16^175
 ;;^UTILITY(U,$J,358.4,1557,0)
 ;;=OTHER DISORDERS^17^175
 ;;^UTILITY(U,$J,358.4,1558,0)
 ;;=PERSONALITY DISORDERS^18^175
 ;;^UTILITY(U,$J,358.4,1559,0)
 ;;=PREVENTION/COUNSELING/SCREEN^20^175
 ;;^UTILITY(U,$J,358.4,1560,0)
 ;;=PSYCHOSIS/OTHER^22^175
 ;;^UTILITY(U,$J,358.4,1561,0)
 ;;=SCHIZOPHRENIA^23^175
 ;;^UTILITY(U,$J,358.4,1562,0)
 ;;=SEXUAL DISORDERS^25^175
 ;;^UTILITY(U,$J,358.4,1563,0)
 ;;=SLEEP DISORDERS^26^175
 ;;^UTILITY(U,$J,358.4,1564,0)
 ;;=SOMATIFORM DISORDERS^27^175
 ;;^UTILITY(U,$J,358.4,1565,0)
 ;;=SUBSTANCE RELATED DISORDERS^28^175
 ;;^UTILITY(U,$J,358.4,1566,0)
 ;;=V CODES^29^175
 ;;^UTILITY(U,$J,358.4,1567,0)
 ;;=OTHER^4^176
 ;;^UTILITY(U,$J,358.4,1568,0)
 ;;=CASE MANAGEMENT SERVICES^1^176
 ;;^UTILITY(U,$J,358.4,1569,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^3^176
 ;;^UTILITY(U,$J,358.4,1570,0)
 ;;=EDUCATION/TRAINING^2^176
 ;;^UTILITY(U,$J,358.4,1571,0)
 ;;=PSYCHIATRIC THERAPY^5^176
 ;;^UTILITY(U,$J,358.4,1572,0)
 ;;=PSYCHIATRIC THERAPY^8^177
 ;;^UTILITY(U,$J,358.4,1573,0)
 ;;=OTHER^7^177
 ;;^UTILITY(U,$J,358.4,1574,0)
 ;;=CASE MANAGEMENT SERVICES^1^177
 ;;^UTILITY(U,$J,358.4,1575,0)
 ;;=HOME HEALTH VISIT^5^177
 ;;^UTILITY(U,$J,358.4,1576,0)
 ;;=COMMUNITY RESIDENTIAL CARE^2^177
 ;;^UTILITY(U,$J,358.4,1577,0)
 ;;=SMOKING/TOBACCO USE CESSATION^9^177
 ;;^UTILITY(U,$J,358.4,1578,0)
 ;;=NON-EMER PATIENT TRANSPORT^6^177
 ;;^UTILITY(U,$J,358.4,1579,0)
 ;;=HEALTH AND BEHAVIOR ASSESSMENT^4^177
 ;;^UTILITY(U,$J,358.4,1580,0)
 ;;=EDUCATION/TRAINING^3^177
 ;;^UTILITY(U,$J,358.4,1581,0)
 ;;=ADJUSTMENT DISORDERS^2^178
 ;;^UTILITY(U,$J,358.4,1582,0)
 ;;=ANXIETY DISORDERS^4^178
 ;;^UTILITY(U,$J,358.4,1583,0)
 ;;=AMNESTICS^3^178
 ;;^UTILITY(U,$J,358.4,1584,0)
 ;;=ORGANIC DISORDERS^13^178
 ;;^UTILITY(U,$J,358.4,1585,0)
 ;;=DEMENTIA^8^178
 ;;^UTILITY(U,$J,358.4,1586,0)
 ;;=DELIRIUM^7^178
 ;;^UTILITY(U,$J,358.4,1587,0)
 ;;=BIPOLAR DISORDERS^5^178
 ;;^UTILITY(U,$J,358.4,1588,0)
 ;;=PSYCHOSIS/OTHER^17^178
 ;;^UTILITY(U,$J,358.4,1589,0)
 ;;=PERSONALITY DISORDERS^15^178
 ;;^UTILITY(U,$J,358.4,1590,0)
 ;;=SEXUAL DISORDERS^19^178
 ;;^UTILITY(U,$J,358.4,1591,0)
 ;;=SLEEP DISORDERS^20^178
 ;;^UTILITY(U,$J,358.4,1592,0)
 ;;=OTHER DISORDERS^14^178
 ;;^UTILITY(U,$J,358.4,1593,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^178
 ;;^UTILITY(U,$J,358.4,1594,0)
 ;;=V CODES^23^178
 ;;^UTILITY(U,$J,358.4,1595,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^178
 ;;^UTILITY(U,$J,358.4,1596,0)
 ;;=DEPRESSION^9^178
 ;;^UTILITY(U,$J,358.4,1597,0)
 ;;=MOOD DISORDERS (OTHER)^11^178
 ;;^UTILITY(U,$J,358.4,1598,0)
 ;;=SCHIZOPHRENIA^18^178
 ;;^UTILITY(U,$J,358.4,1599,0)
 ;;=SOMATIFORM DISORDERS^21^178
 ;;^UTILITY(U,$J,358.4,1600,0)
 ;;=EATING DISORDERS^10^178
 ;;^UTILITY(U,$J,358.4,1601,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^178
 ;;^UTILITY(U,$J,358.4,1602,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^178
 ;;^UTILITY(U,$J,358.4,1603,0)
 ;;=BRAIN DISORDERS^6^178
 ;;^UTILITY(U,$J,358.4,1604,0)
 ;;=NEW PATIENT^2^179
 ;;^UTILITY(U,$J,358.4,1605,0)
 ;;=ESTABLISHED PATIENT^1^179
 ;;^UTILITY(U,$J,358.4,1606,0)
 ;;=CONSULTATIONS^3^179
 ;;^UTILITY(U,$J,358.4,1607,0)
 ;;=NEURO^4^180
 ;;^UTILITY(U,$J,358.4,1608,0)
 ;;=MENTAL HEALTH^3^180
 ;;^UTILITY(U,$J,358.4,1609,0)
 ;;=HISTORY OF ILLNESS^2^180
 ;;^UTILITY(U,$J,358.4,1610,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^5^180
 ;;^UTILITY(U,$J,358.4,1611,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^6^180
 ;;^UTILITY(U,$J,358.4,1612,0)
 ;;=OTHER REASONS^8^180
 ;;^UTILITY(U,$J,358.4,1613,0)
 ;;=TBI SCREENING^7^180
 ;;^UTILITY(U,$J,358.4,1614,0)
 ;;=CAUSES OF INJURY-SECONDARY^1^180
 ;;^UTILITY(U,$J,358.4,1615,0)
 ;;=IMMUNIZATIONS^5^181
 ;;^UTILITY(U,$J,358.4,1616,0)
 ;;=COUNSELING^1^181
 ;;^UTILITY(U,$J,358.4,1617,0)
 ;;=EDUCATION^2^181
 ;;^UTILITY(U,$J,358.4,1618,0)
 ;;=EVALUATIONS^3^181
 ;;^UTILITY(U,$J,358.4,1619,0)
 ;;=IMMUNIZATION ADMINISTRATION^4^181
 ;;^UTILITY(U,$J,358.4,1620,0)
 ;;=TREATMENT PROCEDURES^6^181
 ;;^UTILITY(U,$J,358.4,1621,0)
 ;;=NEW PATIENT^2^182
 ;;^UTILITY(U,$J,358.4,1622,0)
 ;;=ESTABLISHED PATIENT^1^182
 ;;^UTILITY(U,$J,358.4,1623,0)
 ;;=CONSULTATIONS^3^182
 ;;^UTILITY(U,$J,358.4,1624,0)
 ;;=ABRASION w/o INFECTION^1^183
 ;;^UTILITY(U,$J,358.4,1625,0)
 ;;=ABRASION w/ INFECTION^2^183
 ;;^UTILITY(U,$J,358.4,1626,0)
 ;;=ABSCESS/CELLULITIS^3^183
 ;;^UTILITY(U,$J,358.4,1627,0)
 ;;=ACNE^4^183
 ;;^UTILITY(U,$J,358.4,1628,0)
 ;;=ALOPEICA^5^183
 ;;^UTILITY(U,$J,358.4,1629,0)
 ;;=BURNS^6^183
 ;;^UTILITY(U,$J,358.4,1630,0)
 ;;=CANDIDIASIS^7^183
 ;;^UTILITY(U,$J,358.4,1631,0)
 ;;=CELLULITIS^8^183
 ;;^UTILITY(U,$J,358.4,1632,0)
 ;;=DERMATITIS^9^183
 ;;^UTILITY(U,$J,358.4,1633,0)
 ;;=DERMATOPHYTOSIS^10^183
 ;;^UTILITY(U,$J,358.4,1634,0)
 ;;=ECZEMA^11^183
 ;;^UTILITY(U,$J,358.4,1635,0)
 ;;=EDEMA^12^183
 ;;^UTILITY(U,$J,358.4,1636,0)
 ;;=ERYTHEMA^13^183
 ;;^UTILITY(U,$J,358.4,1637,0)
 ;;=EXPOSURE TO HEALTH HAZARDS^14^183
 ;;^UTILITY(U,$J,358.4,1638,0)
 ;;=FOLLICULITIS^15^183
 ;;^UTILITY(U,$J,358.4,1639,0)
 ;;=FURUNCLE^16^183
 ;;^UTILITY(U,$J,358.4,1640,0)
 ;;=GRANULOMA^17^183
 ;;^UTILITY(U,$J,358.4,1641,0)
 ;;=HERPES^35^183
 ;;^UTILITY(U,$J,358.4,1642,0)
 ;;=HISTORY^36^183
 ;;^UTILITY(U,$J,358.4,1643,0)
 ;;=ICHTHYOSIS^38^183
 ;;^UTILITY(U,$J,358.4,1644,0)
 ;;=INSECT BITE w/o INFECTION^39^183
 ;;^UTILITY(U,$J,358.4,1645,0)
 ;;=INSECT BITE w/INFECTION^40^183
 ;;^UTILITY(U,$J,358.4,1646,0)
 ;;=KERATOSIS^42^183
 ;;^UTILITY(U,$J,358.4,1647,0)
 ;;=LACERATION^44^183
 ;;^UTILITY(U,$J,358.4,1648,0)
 ;;=LESION^46^183
 ;;^UTILITY(U,$J,358.4,1649,0)
 ;;=LICHENIFICATION^47^183
 ;;^UTILITY(U,$J,358.4,1650,0)
 ;;=LUPUS^48^183
 ;;^UTILITY(U,$J,358.4,1651,0)
 ;;=MELANOMA^50^183
 ;;^UTILITY(U,$J,358.4,1652,0)
 ;;=NAIL DISEASE^53^183
 ;;^UTILITY(U,$J,358.4,1653,0)
 ;;=NEOPLASM-BENIGN^54^183
 ;;^UTILITY(U,$J,358.4,1654,0)
 ;;=NEOPLASM-IN SITU^56^183
 ;;^UTILITY(U,$J,358.4,1655,0)
 ;;=NEOPLASM-OTHER^57^183
 ;;^UTILITY(U,$J,358.4,1656,0)
 ;;=NEURODERMATITIS^58^183
 ;;^UTILITY(U,$J,358.4,1657,0)
 ;;=PEDICULOSIS^61^183
 ;;^UTILITY(U,$J,358.4,1658,0)
 ;;=PITYRIASIS^62^183
 ;;^UTILITY(U,$J,358.4,1659,0)
 ;;=PRURITUS^63^183
 ;;^UTILITY(U,$J,358.4,1660,0)
 ;;=PSORIASIS^64^183
 ;;^UTILITY(U,$J,358.4,1661,0)
 ;;=STASIS^66^183
 ;;^UTILITY(U,$J,358.4,1662,0)
 ;;=ULCER^68^183
 ;;^UTILITY(U,$J,358.4,1663,0)
 ;;=ULCER-LOWER EXTREMITY^69^183
 ;;^UTILITY(U,$J,358.4,1664,0)
 ;;=URTICARIA^70^183
 ;;^UTILITY(U,$J,358.4,1665,0)
 ;;=VARICOSE VEINS^71^183
 ;;^UTILITY(U,$J,358.4,1666,0)
 ;;=WOUND^73^183
 ;;^UTILITY(U,$J,358.4,1667,0)
 ;;="A" MISC DIAGNOSIS^5.1^183
 ;;^UTILITY(U,$J,358.4,1668,0)
 ;;="B" MISC DIAGNOSIS^6.1^183
 ;;^UTILITY(U,$J,358.4,1669,0)
 ;;="C" MISC DIAGNOSIS^8.1^183
 ;;^UTILITY(U,$J,358.4,1670,0)
 ;;="D" MISC DIAGNOSIS^10.1^183
 ;;^UTILITY(U,$J,358.4,1671,0)
 ;;="E" MISC DIAGNOSIS^14.1^183
 ;;^UTILITY(U,$J,358.4,1672,0)
 ;;="F" MISC DIAGNOSIS^16.1^183
 ;;^UTILITY(U,$J,358.4,1673,0)
 ;;="H" MISC DIAGNOSIS^37^183
 ;;^UTILITY(U,$J,358.4,1674,0)
 ;;="I" MISC DIAGNOSIS^41^183
 ;;^UTILITY(U,$J,358.4,1675,0)
 ;;="K" MISC DIAGNOSIS^43^183
